Cowealth Medical China Co.,Ltd.

¥10.85As of Sun 8 Nov 2026, 12:00 UTC
SSE:603122Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (2.34%)
Div yield —
ROE (2.49%)
Diagnostics & Research
Beta (5Y) (0.02)
PE TTM —
TSR TTM 10.83%
Mkt cap ¥4.319B
ROIC (2.58%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥12
9.31%
(5.05%)
Sell 0|5|9|10|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.14
0.15
0.14
0.16
35.94%
30.69%
18.51%
21.88%
Revenue¥M
459.3
477.6
465.5
468.5
7.12%
12.84%
4.41%
3.19%
Peers (US$647.4M)
Cap (US$)
PE
589.6M
93.63x
540.0M
53.92x
Capital
TTM
5Y
10Y
Leveragex
1.434
(0.378)
(0.359)
EBIT/Intx
1.510
0.175
0.165
Own earn%
95.68
(84.82)
(81.53)
Sh yield%
31.32
21.53
20.26
Owners
Insiders/Inst%
1.01
85.20
Short interest%
3.80
SBC / revenue%
2.42
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
13–22
$1 testx
−0.3
Incr. ROIC%
5